Category Archives: Accutane

Featured Stories

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Jury Orders Roche to Pay $1.5 Million to Accutane User for IBD

A woman who developed inflammatory bowel disease (IBD) after taking Hoffman-LaRoche’s acne drug Accutane, has been awarded more than $1.5 million in compensatory damages and medical expenses. This was a retrial of the case; an earlier verdict was overturned on … Continue reading

Posted in Accutane, Health Concerns, Legal News, Pharmaceuticals |

Two Accutane Users Awarded $9 Million Each in Inflammatory Bowel Disease Lawsuit

A New Jersey jury has ordered the maker of Accutane to pay a total of $18 million to two people who developed inflammatory bowel diseases while using the drug.  According to a report from Bloomberg News, Roche Holding AG has … Continue reading

Posted in Accutane, Pharmaceuticals | Tagged |

Accutane Associated with Double Risk of Eye Disorders

A new study has associated the acne medication Accutane (isotretinoin) with an increased chance of developing some form of eye disorder. According to a report from HealthDay News, researchers at Tel Aviv Medical Center in Israel have found that people … Continue reading

Posted in Accutane, Pharmaceuticals | Tagged |

SOL Clock on Drug Lawsuit Doesn’t Start with FDA Warnings, NJ Court Rules

The New Jersey Supreme Court has upheld a lower court’s ruling that Food and Drug Administration (FDA) warnings about the dangers of prescription drugs do not always “start the clock” on the statute of limitations for product liability claims. According … Continue reading

Posted in Accutane, Legal News, Pharmaceuticals |

Accutane Bowel Lawsuits in New Jersey Mass Tort Top 2400

There are now 2,441 < "http://www.yourlawyer.com/topics/overview/Accutane-Side-Effects-Inflammatory-Bowel-Disease-Colitis-Crohns-Disease-Lawyer-Lawsuit-Attorney">Accutane inflammatory bowel disease (IBD) lawsuits pending in a New Jersey mass tort litigation that began five years ago. Over the fall, more than 800 lawsuits were filed in the Accutane litigation, and it is … Continue reading

Posted in Accutane, Pharmaceuticals |

Accutane, Acne, Suicide Linked in New Study

A new Accutane study out of Sweden has linked the controversial acne drug to an increased risk of suicide. The study’s findings support increased mental health monitoring of patients for up to a year after taking Accutane. Approved by the … Continue reading

Posted in Accutane, Pharmaceuticals |

Accutane Puts Users At Risk For Intestinal Disorders

Inflammatory Bowel Disease (IBD)—Ulcerative Colitis and Crohn’s disease—are some of the dangerous side effects linked to Accutane. In 2005, the Accutane label was modified to warn that IBD had been associated its use; however, many believe the warning did not … Continue reading

Posted in Accutane, Pharmaceuticals |

400+ Accutane Lawsuits Filed in Past Two Months

More than 400 Accutane lawsuits alleging the acne drug caused a variety of side effects, including inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, have been filed in a New Jersey mass tort litigation over the past two months. … Continue reading

Posted in Accutane, Pharmaceuticals |

Actor Claims Accutane IBD Ended Career

Actor John Marshall has filed suit against Roche AG, the maker of Accutane. The 43-year-old Marshall, who played U.S. Marine Louden Downey in the 1992 hit movie “A Few Good Men,” claims he developed inflammatory bowel disease, or IBD, from … Continue reading

Posted in Accutane, Pharmaceuticals |

Accutane Settlement in Illinois Lawsuit

Roche Laboratories Inc. and Hoffman-LaRoche Inc., makers of acne drug Accutane, just settled a lawsuit that was pending for seven years. A man alleging Accutane caused his inflammatory bowel disease filed the lawsuit, said the St. Claire Record. Accutane, which … Continue reading

Posted in Accutane, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.